Ryvu Therapeutics announces participation in the UBS 2021 Global Healthcare Virtual Conference and the Erste Group Innovation Conference 2021

Krakow, Poland – May 18, 2021 – Ryvu Therapeutics (WSE:RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, announced today its plan to participate in two upcoming investor conferences: UBS 2021 Global Healthcare Virtual Conference and Erste Group Innovation Conference 2021. 

UBS Global Healthcare Virtual Conference will take place on May 24-26, 2021 and will once again create opportunity to connect corporate leaders with the global investor community, influential policymakers, and industry experts. 

Pawel Przewiezlikowski, Chief Executive Officer at Ryvu Therapeutics, is scheduled to present a corporate overview and research updates on Tuesday, May 25 at 9:00 AM (ET). A live webcast of the presentation can be accessed under “Events & Presentations” in the Investor/Media section of the Company’s website, https://ryvu.com/investors-media/events-presentations/. After the event a 30-day archival replay will be also available.  

Erste Group Innovation Conference, will take place on May 26, 2021, and is a conference organized jointly by Erste Group Bank AG and Warsaw Stock Exchange, with an aim to bring together innovative European companies with CEE institutional investors.  

Ryvu will host investor meetings during both events.